Cargando…
Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
The outcomes of pediatric acute lymphoblastic leukemia (ALL) have improved remarkably during the last five decades. Such improvements were made possible by the incorporation of new diagnostic technologies, the effective administration of conventional chemotherapeutic agents, and the provision of bet...
Autores principales: | Inaba, Hiroto, Pui, Ching-Hon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124693/ https://www.ncbi.nlm.nih.gov/pubmed/33946897 http://dx.doi.org/10.3390/jcm10091926 |
Ejemplares similares
-
Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020) -
Personalized therapy in pediatric high-risk B-cell acute lymphoblastic leukemia
por: Karol, Seth E., et al.
Publicado: (2020) -
Precision medicine in acute lymphoblastic leukemia
por: Pui, Ching-Hon
Publicado: (2020) -
Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia
por: Barsan, Valentin, et al.
Publicado: (2022) -
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
por: Lee, Shawn H. R., et al.
Publicado: (2023)